May 25, 2017
Veeva Announces Fiscal 2018 First Quarter Results
Total Revenues of $157.9M, up 32% Year-over-year Subscription Services Revenues of $127.3M, up 33% Year-over-year Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal first quarter ended April 30, 2017. “Q1 was another great quarter across the board,” said CEO Peter Gassner. “Our continued momentum further demonstrates we have the proven innovation engine, disciplined execution, and customer success focus to continue to achieve long-term leadership.” Fiscal 2018 First Quarter Results: Revenues: Total revenues for the first quarter were $157.9 million, up from $119.8 million one year ago, an increase of 32% year-over-year. Subscription services revenues for the first quarter were $127.3 million, up from $96.0 million one year ago, an increase of 33% year-over-year. Operating income and non-GAAP operating income(1): First quarter operating income was $37.3 million, compared...
April 25, 2017
Veeva Vault EDC Now Available to Streamline Trial Design and Execution
New cloud application delivers a better EDC to allow
clinical data management teams to run the trial they want Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault EDC to help clinical data management teams better run clinical trials. Veeva Vault EDC delivers a flexible, modern cloud application to easily design studies, manage amendments, and improve the speed and quality of data collection. Veeva is bringing together EDC and eSource with CTMS and eTMF to provide the industry’s first and only suite of unified cloud applications to streamline clinical operations and clinical data management. “Veeva Vault EDC allows life sciences companies to run the trial they want, not the trial their technology limits them to,” said Brian Longo , senior vice president and general manager, Veeva Vault EDC. “With a modern cloud EDC, clinical teams can reduce cost and complexity to deliver better data faster and accelerate trial execution.” Traditional EDC systems struggle...
April 19, 2017
TransCelerate Selects Veeva Vault SiteExchange
Veeva and TransCelerate collaborate to simplify document exchange in clinical trials between investigators and sponsors Veeva Systems (NYSE: VEEV) and TransCelerate BioPharma Inc., a non-profit organization with membership comprised of global biopharmaceutical companies, today announced TransCelerate selected Veeva Vault SiteExchange for the Shared Investigator Platform (SIP), a platform that facilitates investigative site collaboration with multiple clinical trial sponsors. The TransCelerate SIP Initiative aims to provide the industry with a centralized platform that will be interoperable with various clinical solutions, streamline communications between investigators and sponsors, and reduce redundant requests during a trial. TransCelerate chose Veeva Vault SiteExchange to simplify document access and exchange through the SIP. Veeva Vault SiteExchange will improve efficiencies and allow clinical trial investigators, sites, and participating sponsors to have immediate and centralized...